Non-Surgical Interventions for the Prevention of Clinically Relevant Postoperative Pancreatic Fistula—A Narrative Review

N Rykina-Tameeva, JS Samra, S Sahni, A Mittal - Cancers, 2023 - mdpi.com
Simple Summary Clinically relevant postoperative pancreatic fistula (CR-POPF) continues to
be the leading cause of morbidity and mortality after pancreatic surgery. Attempts to prevent …

[HTML][HTML] The effect of preoperative chemotherapy and chemoradiotherapy on pancreatic fistula and other surgical complications after pancreatic resection: a …

JC van Dongen, LV Wismans, JA Suurmeijer… - HPB, 2021 - Elsevier
Background Preoperative chemo-or chemoradiotherapy is recommended for borderline-
resectable pancreatic cancer. The aim of this study was to determine the impact of …

[HTML][HTML] Preoperative chemoradiotherapy but not chemotherapy is associated with reduced risk of postoperative pancreatic fistula after pancreatoduodenectomy for …

LV Wismans, JA Suurmeijer, JC van Dongen… - Surgery, 2024 - Elsevier
Background Postoperative pancreatic fistula remains the leading cause of significant
morbidity after pancreatoduodenectomy for pancreatic ductal adenocarcinoma. Preoperative …

A deep pancreas is a novel predictor of pancreatic fistula after pancreaticoduodenectomy in patients with a nondilated main pancreatic duct

M Iseki, H Noda, F Watanabe, T Kato, Y Endo… - Surgery, 2021 - Elsevier
Background We investigated the risk factors for clinically relevant postoperative pancreatic
fistula after pancreaticoduodenectomy in patients with a nondilated main pancreatic duct …

Neoadjuvant chemotherapy associated with isotoxic high‐dose stereotactic body radiotherapy does not increase postoperative complications after …

J Navez, C Bouchart, L Mans, S Devos… - Journal of Surgical …, 2023 - Wiley Online Library
Abstract Background and Objectives The role of radiotherapy in the therapeutic sequence of
nonmetastatic pancreatic cancer (PC) is controversial, including isotoxic high‐dose …

[PDF][PDF] Impact of preoperative chemotherapy on surgical results in 139 patients with locally advanced pancreatic cancer

M Petrikowski, T Fahlbusch… - Hepatobiliary …, 2024 - cdn.amegroups.cn
Background: The establishment of preoperative chemotherapy (PCT) with FOLFIRINOX and
gemcitabine/nab-paclitaxel in recent years has enabled resectability in many patients with …

[HTML][HTML] Selected pre-operative factors which affect pancreaticoduodenectomy outcomes: A systematic review

TB Russell, PL Labib, S Aroori - Annals of Pancreatic Cancer, 2021 - apc.amegroups.org
Background: Pancreatic ductal adenocarcinoma (PDAC) affecting the head of the pancreas
carries a dismal prognosis. For those with early disease, pancreaticoduodenectomy (PD) …

Neoadjuvant Chemoradiotherapy and Postoperative Digestive Fistula: Neoadjuvant Chemoradiotherapy and Postoperative Digestive Fistula

I Araujo-Filho, ACM Rêgo - JOURNAL OF SURGICAL AND …, 2024 - periodicos.ufrn.br
The pivotal role of neoadjuvant chemotherapy and radiotherapy in enhancing the
management of gastrointestinal cancers is incontrovertible. However, their implications for …

[PDF][PDF] AND META-ANALYSIS OF COMPARATIVE STUDIES

JC van Dongen, LV Wismans, JA Suurmeijer… - PANCREATIC … - pure.eur.nl
Background Preoperative chemo-or chemoradiotherapy is recommended for borderline-
resectable pancreatic cancer. The aim of this study was to determine the impact of …